Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F)

Added 385 days ago (29.04.2021)

Authors: Noeman Ardalan; Abbas Akhavan Sepahi; Ramazan Ali Khavari-Nejad